Glp-1 receptor activation
Glucose-dependent promotion of insulin secretion, inhibition of glucagon release, and reduction of glycated hemoglobin and postprandial blood glucose
It delays gastric emptying, enhances a feeling of fullness, suppresses appetite and reduces food intake
2. Glucagon GCGR receptor activation (a characteristic target of Masadol peptide)
Activate GCGR in the liver and adipose tissue, promote fat decomposition and fatty acid oxidation, and enhance energy consumption; It has a remarkable effect on fatty liver and liver fat reduction, and is superior to the simple GLP-1 single-target drug Innovent Biologics...
3. Multiple metabolic benefits
Lose weight and reduce waist circumference; It can simultaneously improve blood lipid, blood pressure, blood uric acid, liver enzymes and insulin resistance, and is suitable for type 2 diabetic patients with abdominal obesity and fatty liver. Xinhua News Agency
IDA